Showing results (31-40 of 283) with videos related to
Sort By:
Pageof 29
International Clinical Psychopharmacology|May 1, 1996
The new generation of antipsychotic drugsC A Tamminga, A C LahtiProgress in Neuro-Psychopharmacology & Biological Psychiatry|December 3, 1999
Effect of amphetamine, alpha-methyl-p-tyrosine (alpha-MPT) and antipsychotic agents on dopamine D2-type receptor occupancy in ratsR A Lahti, C A TammingaMolecular Psychiatry|September 2, 2004
Phenotype of schizophrenia: a review and formulationC A Tamminga, H H HolcombExpert Opinion on Investigational Drugs|July 2, 2005
Olanzapine (Zyprexa):characteristics of a new antipsychoticC A Tamminga, J M KanePsychopharmacology|January 1, 1979
Treatment of Schizophrenia with ergot derivativesC A Tamminga, M H SchafferNeuroscience|July 28, 2015
Schizophrenia: Evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiologyC A Tamminga, R S ZukinCurrent Pharmaceutical Biotechnology|January 31, 2012
Treating impaired cognition in schizophreniaH M Ibrahim, C A TammingaDialogues in Clinical Neuroscience|October 29, 2011
Treatments for chronic psychosisC A Tamminga, A C LahtiExpert Opinion on Investigational Drugs|July 2, 2005
Sertindole (Serdolect): preclinical and clinical findings of a new atypical antipsychoticJ M Kane, C A TammingaSynapse (New York, N.Y.)|August 1, 1996
Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48-hour time courseX M Gao, C A TammingaPageof 29